BioAdaptives, Inc. (BDPT)
OTCMKTS · Delayed Price · Currency is USD
0.0030
-0.001775 (-37.17%)
At close: Jun 15, 2026
BioAdaptives Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.02 | 0.02 | 0.01 | 0.03 | 0.02 | 0.02 | |
Revenue Growth (YoY) | 3424.74% | 44.27% | -55.65% | 66.31% | -13.15% | 21.13% |
Cost of Revenue | 0.01 | 0.01 | 0.09 | 0.02 | 0.01 | 0.01 |
Gross Profit | 0.02 | 0.01 | -0.08 | 0.01 | 0.01 | 0.01 |
Selling, General & Admin | 1 | 1.05 | 0.5 | 0.21 | 0.37 | 0.35 |
Amortization of Goodwill & Intangibles | 0 | 0 | 0 | 0.03 | 0.06 | 0.13 |
Operating Expenses | 1.01 | 1.05 | 0.51 | 0.24 | 0.43 | 0.65 |
Operating Income | -0.99 | -1.04 | -0.58 | -0.23 | -0.42 | -0.64 |
Interest Expense | -0.15 | -0.07 | -0.09 | -0.16 | -0.29 | -0.27 |
Other Non Operating Income (Expenses) | -0.47 | -0.58 | -0.21 | -0.31 | -0.18 | -0.09 |
EBT Excluding Unusual Items | -1.61 | -1.69 | -0.88 | -0.7 | -0.9 | -1 |
Gain (Loss) on Sale of Investments | - | - | - | -0 | -0 | -0 |
Asset Writedown | - | - | -0.02 | - | - | - |
Other Unusual Items | 0.13 | 0.13 | - | -0.01 | - | -0.05 |
Pretax Income | -1.47 | -1.56 | -0.9 | -0.71 | -0.9 | -1.05 |
Earnings From Continuing Operations | -1.47 | -1.56 | -0.9 | -0.71 | -0.9 | -1.05 |
Net Income | -1.47 | -1.56 | -0.9 | -0.71 | -0.9 | -1.05 |
Net Income to Common | -1.47 | -1.56 | -0.9 | -0.71 | -0.9 | -1.05 |
Shares Outstanding (Basic) | 11 | 10 | 8 | 6 | 1 | 0 |
Shares Outstanding (Diluted) | 11 | 10 | 8 | 6 | 1 | 0 |
Shares Change (YoY) | 26.42% | 22.61% | 37.57% | 744.97% | 214.17% | 65.51% |
EPS (Basic) | -0.14 | -0.15 | -0.11 | -0.12 | -1.27 | -4.67 |
EPS (Diluted) | -0.14 | -0.15 | -0.11 | -0.12 | -1.27 | -4.67 |
Free Cash Flow | -0.52 | -0.53 | -0.25 | -0.22 | -0.23 | -0.16 |
Free Cash Flow Per Share | -0.05 | -0.05 | -0.03 | -0.04 | -0.32 | -0.70 |
Gross Margin | 69.81% | 68.37% | - | 37.88% | 41.49% | 51.10% |
Operating Margin | -4166.29% | -5701.79% | -4610.39% | -801.40% | -2456.33% | -3216.43% |
Profit Margin | -6186.31% | -8523.35% | -7097.33% | -2494.19% | -5214.08% | -5309.20% |
Free Cash Flow Margin | -2189.64% | -2921.68% | -1969.51% | -783.38% | -1323.12% | -802.24% |
EBITDA | -0.99 | -1.04 | -0.58 | -0.2 | -0.36 | -0.5 |
D&A For EBITDA | 0.01 | 0 | 0 | 0.03 | 0.06 | 0.13 |
EBIT | -0.99 | -1.04 | -0.58 | -0.23 | -0.42 | -0.64 |